
Human Mesothelin 20-28, SLLFLLFSL
Description
About Human Mesothelin 20-28, SLLFLLFSL
The Human Mesothelin Peptide (IEDB: 2242188) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Mesothelin Peptide, H-SLLFLLFSL-OH (Uniprot: Q13421 aa: 20-28) from JPT is produced under strict quality control and quality management.
Human Mesothelin 20-28, SLLFLLFSL - Specifications
- Peptide sequence: H-SLLFLLFSL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Mesothelin 20-28, SLLFLLFSL
References:
Read References with JPT’s Antigen Peptides
Human Mesothelin 20-28, SLLFLLFSL has been described in:
Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS., Front Immunol, 2018 (PMID: 30245692)
Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human., Clin Cancer Res, 2018 (PMID: 29233904)
Documentation
Documentation for Human Mesothelin 20-28, SLLFLLFSL
Properties
Properties of Human Mesothelin 20-28, SLLFLLFSL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Mesothelin 20-28, SLLFLLFSL
Information | Values |
---|---|
Sequence: | H-SLLFLLFSL-OH |
Specifications: | 9mer peptide as TFA salt |